Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS
Top Cited Papers
- 28 November 2004
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 8 (1) , 85-92
- https://doi.org/10.1038/nn1360
Abstract
Neurotrophin treatment has so far failed to prolong the survival of individuals affected with amyotrophic lateral sclerosis (ALS), an incurable motoneuron degenerative disorder. Here we show that intracerebroventricular (i.c.v.) delivery of recombinant vascular endothelial growth factor (Vegf) in a SOD1G93A rat model of ALS delays onset of paralysis by 17 d, improves motor performance and prolongs survival by 22 d, representing the largest effects in animal models of ALS achieved by protein delivery. By protecting cervical motoneurons, i.c.v. delivery of Vegf is particularly effective in rats with the most severe form of ALS with forelimb onset. Vegf has direct neuroprotective effects on motoneurons in vivo, because neuronal expression of a transgene expressing the Vegf receptor prolongs the survival of SOD1G93A mice. On i.c.v. delivery, Vegf is anterogradely transported and preserves neuromuscular junctions in SOD1G93A rats. Our findings in preclinical rodent models of ALS may have implications for treatment of neurodegenerative disease in general.Keywords
This publication has 32 references indexed in Scilit:
- ALS, IGF-1 and gene therapy: ‘it's never too late to mend’Gene Therapy, 2004
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic deathNature Genetics, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Of mice and men: Reconciling preclinical ALS mouse studies and human clinical trialsAnnals of Neurology, 2003
- Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approachesNature Neuroscience, 2002
- The GDNF family: Signalling, biological functions and therapeutic valueNature Reviews Neuroscience, 2002
- Early Onset of Severe Familial Amyotrophic Lateral Sclerosis with a SOD-1 Mutation: Potential Impact of CNTF as a Candidate Modifier GeneAmerican Journal of Human Genetics, 2002
- Delivery of Neurotrophic Factors to the Central Nervous SystemClinical Pharmacokinetics, 2001
- Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4.The Journal of cell biology, 1994
- Mice lacking brain-derived neurotrophic factor develop with sensory deficitsNature, 1994